There are 2949 resources available
666P - Prognostic role of docetaxel-induced reduction of free testosterone serum levels in metastatic prostate cancer patients
Presenter: Christoph Reuter
Session: E-Poster Display
Resources:
Abstract
667P - Impact of pretreatment neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) on overall survival (OS) in patients (p) with metastatic castration-sensitive prostate cancer (mCSPC) treated with docetaxel (D) plus androgen-deprivation therapy (ADT)
Presenter: Lucía Notario
Session: E-Poster Display
Resources:
Abstract
668P - Clinical factors that are prognostic for survival outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223
Presenter: Esmail Al-Ezzi
Session: E-Poster Display
Resources:
Abstract
669P - Body composition and clinical outcomes in men with metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Andrew Hahn
Session: E-Poster Display
Resources:
Abstract
670P - LINAC-based re-irradiation for locally recurrent prostate cancer after first course radiotherapy
Presenter: Francesco Cuccia
Session: E-Poster Display
Resources:
Abstract
671P - Prospective assessment of AR splice variant and PSMA detection on circulating tumour cells of mCRPC patients: Preliminary results of PRIMERA trial (NCT04188275)
Presenter: Giulio Francolini
Session: E-Poster Display
Resources:
Abstract
672P - Fracture risk in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra 223)
Presenter: Adham Hijab
Session: E-Poster Display
Resources:
Abstract
673P - Assessing bone health and osteoporotic risk in patients requiring anti androgen therapy for prostate cancer
Presenter: Nicola Hannaway
Session: E-Poster Display
Resources:
Abstract
674P - Evaluation of cognitive function (CogF) in trials testing new-generation hormonal treatments (NGHT) in patients with prostate cancer (PC): A systematic review
Presenter: Laura Marandino
Session: E-Poster Display
Resources:
Abstract
675P - HER2 expression in circulating tumour cells is associated with poor outcomes in patients with metastatic castration resistant prostate cancer
Presenter: Denis Maillet
Session: E-Poster Display
Resources:
Abstract